Anjalee Khemlani, Yahoo Finance

Anjalee Khemlani

Yahoo Finance

New York, NY, United States

Contact Anjalee

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

  • Cashay
  • Yahoo

Recent articles by Anjalee:

FDA 'too slow' amid baby formula crisis, commissioner testifies

FDA Commissioner Dr. Robert Califf testified before a U.S. House subcommittee about the ongoing baby formula shortage. → Read More

What's being done to address the baby formula shortage

The U.S. is experiencing a shortage of baby formula. The real turning point came in mid-February, after supply chain constraints were already pressuring the sector. → Read More

FDA expects baby formula shortage to improve in 'next couple of months'

FDA anticipates increased supply of baby formula in next couple of months. → Read More

What you hear in DC doesn't reflect what's going across the US: Fmr. US Surgeon General

Since leaving his post as U.S. Surgeon General in the Trump administration, Dr. Jerome Adams has taken to Twitter and other social media to advocate for... → Read More

FDA limits use of J&J COVID-19 vaccine over blood clot concerns

FDA follows CDC to recommend limitations to J&J COVID-19 vaccine use. → Read More

COVID-19: 'We might not be in a great spot in the fall': Moderna CEO

"This virus is not getting less infectious," Moderna CEO Stéphane Bancel told Yahoo Finance. "As you see more and more infectious variants ... We are not done with this virus mutating," he said. → Read More

Moderna prepares to sell COVID-19 vaccine privately as US delays booster call

Moderna awaits Congress's decision on funding boosters as well as the FDA's decision on which booster to produce, putting it in uncertain territory for 2022. → Read More

The pandemic 'pushed digital health forward like 15 years in three weeks,' health tech CEO

Technology in health care has skyrocketed as a result of the pandemic, though shaking out which platforms and strategies are the most useful is still a work in progress. → Read More

Fmr. U.S. Surgeon General on leaving COVID risk up to individuals

Individual burden has become the COVID-19 pandemic strategy, as U.S. officials see a path out of the pandemic phase. → Read More

Moderna files emergency authorization for kids' COVID-19 vaccine

Moderna starts its filing for an emergency use authorization of its COVID-19 vaccine in kids under 6 years. → Read More

Why Big Tech has struggled in the health-care space, according to Intel chair

Biofourmis is health care's new virtual care unicorn, with a valuation of $1.3 billion and CVS Health coming on board as an investor, the company announced Tuesday. → Read More

Mask mandate ruling is about as 'incoherent as possible:' Former Biden health adviser

Dr. Zeke Emanuel, vice provost of global initiatives at the University of Pennsylvania and former adviser to then–President elect Joe Biden, called a repeal of a federal mask mandate "as incoherent as possible." → Read More

Novavax nears FDA advisory meeting date

Novavax signaled a positive outlook for its vaccine pipeline Wednesday with announcements at the World Vaccine Congress and an update on its COVID-19 vaccine. → Read More

Cigna's Evernorth and Kaiser Permanente team up to expand coverage for remote employees

Cigna's Evernoth unit inks five-year deal with health care giant Kaiser Permanente, opening the door for a broadly-defined partnership. → Read More

US, WHO officials and experts now agree (sort of) on how COVID-19 spreads

The idea that the coronavirus spreads via the air has been known since 2020 by experts across the globe, but pinpointing the definition had remained a point of contention. → Read More

BA.2 surge could determine mask timeline for planes, trains: Fauci

Dr. Anthony Fauci says the next few weeks are critical to determining airline masking requirements. → Read More

Fauci: Omicron is to blame for vaccine delay for children 6 and under

Parents anxiously awaiting a vaccine for their younger children will have to be patient as the U.S. Food and Drug Administration works on two vaccine candidates' applications, Dr. Anthony Fauci told Yahoo Finance. → Read More

Serum Institute mulls Africa plant, mRNA future

The world's largest vaccine maker is eyeing Africa and mRNA ventures, but with caution. Serum Institute CEO Adar Poonawalla shares his thoughts with Yahoo Finance. → Read More

'FemTech' is booming as companies see women as health-care decision makers

FemTech is a growing force in healthtech, and the pandemic's focus on global equity has also created opportunities for emerging markets. → Read More

FDA 'slow-walking' Novavax authorization: Expert

Novavax fans, investors and patients alike, are frustrated by FDA's delays in authorizing COVID-19 vaccine. → Read More